dr. bryce on the use of abiraterone versus docetaxel in patients with prostate cancer
Published 6 years ago • 270 plays • Length 1:22Download video MP4
Download video MP3
Similar videos
-
1:41
dr. oh on abiraterone versus docetaxel in prostate cancer
-
1:37
dr. oh discusses the use of abiraterone and docetaxel in prostate cancer
-
1:32
dr. hahn discusses abiraterone versus docetaxel in prostate cancer
-
0:45
dr. hahn on patients with prostate cancer whom neither docetaxel or abiraterone is an option
-
1:19
comparing abiraterone and docetaxel in prostate cancer treatment
-
1:08
dr. bryce on ongoing research in prostate cancer
-
1:17
dr. oh on the safety profile of docetaxel in prostate cancer
-
1:24
dr. higano on docetaxel for hormone-sensitive prostate cancer
-
1:47
dr. oh on remaining challenges with docetaxel in prostate cancer
-
0:20
copy of dr. hahn discusses abiraterone versus docetaxel in prostate cancer
-
1:53
abiraterone vs docetaxel for metastatic castrate resistant prostate cancer
-
5:16
exciting advances in systemic therapy for prostate cancer: docetaxel and abiraterone
-
7:58
abiraterone and chemotherapy in crpc
-
1:11
dr. burgess on the synergy between abiraterone and adt in prostate cancer
-
1:08
dr. graff on the use of abiraterone in metastatic prostate cancer
-
1:26
dr. oh discusses choosing abiraterone in prostate cancer
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
3:44
updates from the cheiron study: docetaxel plus enzalutamide for mcrpc
-
0:48
dr. kantoff on evolving role of docetaxel in prostate cancer treatment